Therapeutic drug monitoring

Results: 72



#Item
31New drugs – necessity for therapeutic drug monitoring Stephan Krähenbühl Clinical Pharmacology & Toxicology University Hospital Basel

New drugs – necessity for therapeutic drug monitoring Stephan Krähenbühl Clinical Pharmacology & Toxicology University Hospital Basel

Add to Reading List

Source URL: www.sulm.ch

Language: English - Date: 2013-10-23 12:25:48
32The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of medicinal products  World Health

The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of medicinal products World Health

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2013-06-02 18:51:03
33

PDF Document

Add to Reading List

Source URL: media.wiley.com

Language: English - Date: 2013-08-29 13:16:04
34Microsoft Word - ABFT Study Guide (December[removed]docx

Microsoft Word - ABFT Study Guide (December[removed]docx

Add to Reading List

Source URL: abft.org

Language: English - Date: 2014-12-07 18:17:26
35Microsoft Word - ABFT Study Guide (December[removed]docx

Microsoft Word - ABFT Study Guide (December[removed]docx

Add to Reading List

Source URL: www.abft.org

Language: English - Date: 2014-12-07 18:17:26
36Abbott Medical Devices Overview Abbott is a world leader in developing and marketing innovation-driven medical devices for key therapeutic areas that have a significant impact on patients’ lives, including vascular dis

Abbott Medical Devices Overview Abbott is a world leader in developing and marketing innovation-driven medical devices for key therapeutic areas that have a significant impact on patients’ lives, including vascular dis

Add to Reading List

Source URL: prod2.dam.abbott.com

Language: English - Date: 2014-11-26 23:57:19
37The magnitude of personal financial interest: $0 - $10,000 per year Description of the Particular Matter to Which the Waiver Applies: The committee will discuss the clinical pharmacology aspects of pediatric clinical tr

The magnitude of personal financial interest: $0 - $10,000 per year Description of the Particular Matter to Which the Waiver Applies: The committee will discuss the clinical pharmacology aspects of pediatric clinical tr

Add to Reading List

Source URL: www.fda.gov

Language: English
38Disclaimer Statement The attached package contains background information prepared by the Food and Drug Administration (FDA) for the panel members of the advisory committee. The FDA background package might contain asses

Disclaimer Statement The attached package contains background information prepared by the Food and Drug Administration (FDA) for the panel members of the advisory committee. The FDA background package might contain asses

Add to Reading List

Source URL: www.fda.gov

Language: English
39Guideline for measuring voriconazole concentrations

Guideline for measuring voriconazole concentrations

Add to Reading List

Source URL: www.hosp.uky.edu

Language: English - Date: 2011-04-17 15:36:42
40article published online: 8 June 2014 | doi: [removed]nchembio.1554 Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring

article published online: 8 June 2014 | doi: [removed]nchembio.1554 Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring

Add to Reading List

Source URL: www.bakerlab.org

Language: English - Date: 2014-11-26 05:31:48